| 摘要: |
| 慢性乙型肝炎是由乙型肝炎病毒引起的慢性传染病,发病率高。目前的抗病毒治疗以传统肌肉注射药物为主,无法彻底清除病毒,且存在药物副作用、耐药及患者需长期或终生服药等局限性。而DNA疫苗作为一种新兴的治疗策略,因能同时诱导体液及细胞免疫反应及稳定性高的潜力而备受关注,并在临床前动物模型试验中展现了较好的结果。DNA疫苗可通过联合治疗、佐剂及电穿孔技术增强质粒DNA的摄取效率,从而显著增强疗效。本文综述了当前DNA疫苗在慢性乙型肝炎治疗中的研究进展,包括其作用机制、动物模型中的临床前研究、临床试验及未来的发展方向。 |
| 关键词: DNA疫苗 乙型肝炎病毒 免疫治疗 电穿孔 |
| DOI:10.13506/j.cnki.jpr.2025.07.013 |
| 基金项目:国家重点研发计划项目(No.2022YFC2305001) |
|
|
|
| Research status and progress on DNA Vaccines for chronic hepatitis B |
| PENG Siqi,SUN Long |
| (Department of Infectious Diseases, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China) |
| Abstract: |
| Chronic hepatitis B (CHB) is a chronic infectious disease caused by the hepatitis B virus (HBV), with a high global prevalence. Current antiviral therapies primarily rely on traditional intramuscular injection drugs, which still face limitations such as incomplete viral clearance, drug side effects, drug resistance, and the need for long-term or lifelong medication. As an emerging therapeutic strategy, DNA vaccines have garnered significant attention due to their potential to simultaneously induce humoral and cellular immune responses and their high stability. Preclinical studies in animal models have demonstrated promising results. By combining adjuvants and electroporation techniques, the uptake efficiency of plasmid DNA can be enhanced, significantly improving therapeutic efficacy. Preliminary results from related clinical trials have also been encouraging. This review summarizes the current research progress of DNA vaccines in CHB treatment, including their mechanisms of action, preclinical studies in animal models, clinical trials, distinctions from RNA vaccines, and future development directions. |
| Key words: DNA vaccines Hepatitis B virus Immunotherapy Electroporation |